Drug Index

Mechanism :

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic, and antipyretic activities. The mechanism of action of meloxicam, like that of other NSAIDs, may be related to prostaglandin synthetase (cyclo-oxygenase) inhibition.

Indication :

  • Juvenile idiopathic arthritis pain
  • Musculoskeletal pain disorders

Contraindications :

Contraindicated in patients with known hypersensitivity to meloxicam or the excipients, in patients with active peptic ulceration or gastro intestinal complaints, in patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic/anaphylactoid reactions to NSAIDs have been reported in such patients.

Use with caution in case of renal, hepatic or cardiac impairment.

Dosing :

>2 years:
0.125 mg/kg/day PO.
Max: 7.5 mg/day.

Adverse Effect :

Gastrointestinal discomfort, indigestion, nausea, diarrhea, occasionally bleeding and ulceration, headache, dizziness, vertigo, fluid retention, upper respiratory tract infections, hypersensitivity reactions like bronchospasm, rashes have been reported. Local discomfort, burning or itching and occasionally bleeding may occur with NSAID suppositories. Disturbances of blood count have been described in patients taking meloxicam.

Interaction :

ACE-inhibitors: NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors.
Diuretics: Can reduce the natriuretic effect-of furosemide and thiazides in some patients. This response has been attributed to inhibition of renal prostaglandin synthesis.
Lithium: When indomethacin and lithium are administered concurrently, subjects should be observed carefully for signs of lithium toxicity.
Methotrexate: Enhances the toxicity of methotrexate. Caution should be used when NSAIDs are administered concomitantly with methotrexate.
Warfarin: Effects of warfarin and NSAIDs on GI bleeding are synergistic, such that the users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone.
Cidofovir: Contraindicated.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-20Dose as in normal renal function, but avoid if possible
<10Dose as in normal renal function, but avoid if possible Only use if on dialysis

Dose in Patients undergoing Renal Replacement Therapies
CAPDNot dialysed. Dose as in normal renal function
HDNot dialysed. Dose as in normal renal function
HDF/High fluxUnlikely to be dialysed. Dose as in normal renal function
CAV/VVHDNot dialysed. Dose as in GFR=10–20 mL/min

Hepatic Dose :

Mild to moderate hepatic impairment: No dosage adjustments are needed.
Severe hepatic impairment: Use is contraindicated.
09/26/2020 20:18:29 Meloxicam
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0